The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
Clinical trial NCT02982434 · UNKNOWN
Trial details
- NCT number
- NCT02982434
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.